DEA Concurs: Marijuana Meets Schedule III Criteria
FDA Law Blog: Biosimilars
MAY 5, 2024
Houck — The Associated Press reported on Tuesday following confirmation by five anonymous individuals with knowledge that the Drug Enforcement Administration (“DEA”) is moving to reschedule marijuana from schedule I to the less stringently controlled schedule III. FDA/HHS concluded that marijuana does not meet schedule I criteria.
Let's personalize your content